FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to manufacturing solid medicinal formulations of preparations used for reducing resistance of heart coronary vessels and enhancing blood stream, reducing frequency of heart contractions, reducing myocardium requirement for oxygen and enhancing myocardium energetic reserves. Medicinal formulation comprises the following components: amiodaronum hydrochloride, starch, microcrystalline cellulose, polyvinylpyrrolidone, maltodextrin, magnesium stearate, primelose and lactose. Also, invention discloses a method for preparing the above mentioned medicinal formulation. Invention provides enhancing bioavailability and stability of prepared medicinal formulation.
EFFECT: improved preparing method, valuable medicinal properties of formulation.
2 cl, 1 tbl, 1 ex
